NCT Number: NCT00002575
Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer
RATIONALE: Less invasive types of surgery may help reduce the number of side effects and improve recovery. It is not yet known which type of surgery is more effective for colon cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of laparoscopic-assisted colectomy with open colectomy in treating patients who have colon cancer.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
Tom Baker Cancer Center - Calgary, Calgary, Alberta, Canada
About this study
OBJECTIVES:
- Compare the disease-free and overall survival rates of patients with colon cancer treated with laparoscopic-assisted colectomy vs open colectomy.
- Compare the safety of these regimens in terms of early and late morbidity and 30-day mortality of these patients.
- Compare the differences in costs and cost effectiveness between these treatments in this patient population.
- Compare the differences in quality of life of patients treated with these regimens. (closed as of 4/30/99)
OUTLINE: This is a randomized, multicenter study. Patients are stratified according to participating center, primary surgeon, site of primary tumor (right vs left vs sigmoid), and American Society of Anesthesiologists disease classification (I and II vs III). Patients are randomized to one of two treatment arms.
The extent of colon resection is identical for both arms.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
- Clinical diagnosis of primary adenocarcinoma
- Involving a single colon segment:
- Right colon from the ileocecal valve up to and including the hepatic flexure
- Left colon from the splenic flexure to the junction of the sigmoid and descending colon
- Sigmoid colon between the descending colon and the rectum (at least 15 cm from the dentate)
- Diagnosis based on physical exam plus either a proctosigmoidoscopy and barium enema or a colonoscopy
- No advanced local disease that renders laparoscopic resection impossible
- No acutely obstructed or perforated colon cancer requiring urgent surgery
- No transverse colon cancer (i.e., between distal hepatic flexure and proximal splenic flexure)
- No stage IV disease
- No rectal cancer (i.e., below the peritoneal reflection, lower edge of tumor less than 15 cm from dentate)
- No American Society of Anesthesiologists IV/V disease classification
- No associated gastrointestinal diseases (i.e., Crohn's, chronic ulcerative colitis, or familial polyposis) that require additional extensive operative evaluation or intervention
PATIENT CHARACTERISTICS:
Age:
- 18 and over
Other:
- No other prior or concurrent malignancy within the past 5 years except superficial squamous cell or basal cell skin cancer or carcinoma in situ of the cervix
- Not pregnant or nursing
- Negative pregnancy test
- Fertile patients must use effective contraception
PRIOR CONCURRENT THERAPY:
Surgery:
- No prohibitive scars/adhesions from prior abdominal surgery
Other:
- No concurrent investigational treatments or invasive diagnostic procedures within 30 days after surgery
Treatment and study plan
Laparoscopic surgery
ProcedurePrimary outcomes
-
Disease-free survival
Time frame: Up to 8 years
- Compare the disease-free and overall survival rates of patients with colon cancer treated with laparoscopic-assisted colectomy vs open colectomy.
- Compare the safety of these regimens in terms of early and late morbidity and 30-day mortality of these patients.
- Compare the differences in costs and cost effectiveness between these treatments in this patient population.
- Compare the differences in quality of life of patients treated with these regimens. (closed as of 4/30/99)
-
Overall survival
Time frame: Up to 8 years
Secondary outcomes
-
Morbidity
Time frame: Up to 8 years
-
Mortality
Time frame: At 30 days
-
Costs and cost effectiveness between these treatments in this patient population
Time frame: Up to 8 years
-
Compare the differences in quality of life of patients treated with these regimens
Time frame: Up to 8 years
Sponsors and collaborators
Lead sponsor
Alliance for Clinical Trials in Oncology
Other
Collaborators
- NCIC Clinical Trials Group
- National Cancer Institute (NCI)
Registry information
Official study title
A PHASE III PROSPECTIVE RANDOMIZED TRIAL COMPARING LAPAROSCOPIC-ASSISTED COLECTOMY VERSUS OPEN COLECTOMY FOR COLON CANCER
Important dates
- Study start
- 1994
- Primary completion
- 2004
- Study completion
- 2009
- First posted
- Apr 10, 2003
- Registry last updated
- Jul 18, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Predictors of Rescue Surgery, Mortality, and Permanent Stoma After Anastomotic Leak Following Colorectal Cancer Resection
NCT07725692
Anastomotic Leak, Colon Cancer
Alexandria, Please Select, Egypt
View Trial DetailsPhase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer
NCT00159484
Colon Cancer, Colonic Diseases
Los Angeles, California, United States
View Trial DetailsOxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
NCT01150045
Colonic Diseases, Colonic Neoplasms
Mobile, Alabama, United States
View Trial DetailsHealth Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer
NCT00819208
Anxiety Disorder, Anxiety Disorders
Detroit, Michigan, United States
View Trial Details